ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
Dow Jones
40,287.53
-0.93%
US Dollar vs MXN
18.0502
0.50%
Brent Oil
81.875
-2.62%
Bitcoin
67,038.85
4.80%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
19/07/202416:09Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NYSE:NENoble Corporation PLC
19/07/202416:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PSMTPriceSmart Inc
19/07/202416:08Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BML-LBank of America Corporation
19/07/202416:08PR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le samedi 20 juillet 2024
19/07/202416:07GlobeNewswire Inc.ValueZone Reinforces Commitment to Empowering Users with Reliable Passive Income Streams
19/07/202416:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ISRGIntuitive Surgical Inc
19/07/202416:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:SSentinelOne Inc
19/07/202416:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVOSNovo Integrated Sciences Inc
19/07/202416:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ITRMIterum Therapeutics PLC
19/07/202416:05PR Newswire (US)Hair Removal Wax Market size is set to grow by USD 375.15 million from 2023-2027, Benefits of hair removal wax products boost the market, Technavio
19/07/202416:05PR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Saturday, July 20, 2024
19/07/202416:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
19/07/202416:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TTOOT2 Biosystems Inc
19/07/202416:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:BARKBARK Inc
19/07/202416:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:POETPOET Technologies Inc
19/07/202416:02ZyCryptoThe DEX Aggregator Landscape: 5 Key Players for 2024COIN:MINAUSDMina
19/07/202416:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLNOSoleno Therapeutics Inc
19/07/202416:02Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:MCACUMonterey Capital Acquisition Corporation
19/07/202416:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:VHAQUViveon Health Acquisition Corporation (CE)
19/07/202416:00Business WireRiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred DividendsNYSE:OPPRiverNorth DoubleLine Strategic Opportunity Fund Inc
19/07/202416:00GlobeNewswire Inc.Aptose Announces Receipt of Deficiency Notice from NasdaqTSX:APSAptose Biosciences Inc
19/07/202416:00Business WireNovo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial ResultsNASDAQ:NVOSNovo Integrated Sciences Inc
19/07/202416:00GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
19/07/202416:00GlobeNewswire Inc.MetaBeat Partners with FZF Ventures to Lead Web3 Music Innovation
19/07/202416:00GlobeNewswire Inc.Solar Alliance announces closing of second tranche of private placementTSXV:SOLRSolar Alliance Energy Inc
19/07/202416:00PR Newswire (US)First Look: DXL Opens Its Newest Store Concept. Bigger + Better in Manhattan: Offering Great Clothes That Fit Big + Tall Men Shouldn't Be Remarkable. But It Is.
19/07/202416:00PR Newswire (US)SANMINA CORPORATION INVITES YOU TO JOIN ITS THIRD QUARTER FISCAL 2024 EARNINGS CONFERENCE CALLNASDAQ:SANMSanmina Corporation
19/07/202415:56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYNASynaptics Incorporated
19/07/202415:55Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SNTGSentage Holdings Inc
19/07/202415:54Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CDTXCidara Therapeutics Inc

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
CCOM
OILBRENT
Brent Oil
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
FX
USDMXN
US Dollar vs MXN
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
GOOGL
Alphabet
NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
FX
EURMXN
Euro vs MXN
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados